Literature DB >> 14715356

Usefulness of brain natriuretic peptide as a marker for separating cardiac and noncardiac causes of syncope.

Kojiro Tanimoto1, Kazushi Yukiiri, Katsufumi Mizushige, Yuichiro Takagi, Hisashi Masugata, Kaori Shinomiya, Naohisa Hosomi, Tsutomu Takahashi, Koji Ohmori, Masakazu Kohno.   

Abstract

We retrospectively evaluated the feasibility of measuring brain natriuretic peptide to identify cardiac syncope in 148 consecutive patients with syncope. Sixty-one patients with cardiac syncope were identified. A cut-off value of 40 pg/ml was used to determine the cardiac causes of syncope; the sensitivity and specificity for identification of cardiac syncope were 82% and 92%, respectively. Thus, measurement of brain natriuretic peptide concentrations may help confirm cardiac causes of syncope, and merits consideration for incorporation into the algorithm used to diagnose syncope.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715356     DOI: 10.1016/j.amjcard.2003.09.048

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

Review 1.  Collapse query cause: the management of adult syncope in the emergency department.

Authors:  M J Reed; A Gray
Journal:  Emerg Med J       Date:  2006-08       Impact factor: 2.740

2.  Role of brain natriuretic peptide (BNP) in risk stratification of adult syncope.

Authors:  Matthew J Reed; David E Newby; Andrew J Coull; Keith G Jacques; Robin J Prescott; Alasdair J Gray
Journal:  Emerg Med J       Date:  2007-11       Impact factor: 2.740

3.  The role of NT-proBNP in the diagnostics and differentiation of cardiac and reflex syncope in adults: relative importance to clinical presentation and medical examinations.

Authors:  Piotr J Stryjewski; Bohdan Nessler; Agnieszka Kuczaj; Paweł Matusik; Wojciech Gilowski; Jacek Nowak; Ewa Nowalany-Kozielska; Jadwiga Nessler
Journal:  J Interv Card Electrophysiol       Date:  2014-07-10       Impact factor: 1.900

4.  Utility of brain natriuretic peptide assay as a predictor of short term outcomes in patients presenting with syncope to the emergency department.

Authors:  Ahmad Isbitan; Amer Hawatmeh; Yaser Elnahar; Kunal Patel; Zaid Altheeb; Vincent Debari; Ayman Hamdan; Fayez Shamoon
Journal:  Cardiovasc Diagn Ther       Date:  2016-06

Review 5.  Prognostic value of cardiac biomarkers in the risk stratification of syncope: a systematic review.

Authors:  Venkatesh Thiruganasambandamoorthy; Rosa Ramaekers; Mohammed Omair Rahman; Ian Gilmour Stiell; Lindsey Sikora; Sarah-Louise Kelly; Michael Christ; Pierre-Geraud Claret; Matthew James Reed
Journal:  Intern Emerg Med       Date:  2015-10-23       Impact factor: 3.397

6.  Prohormones in the Early Diagnosis of Cardiac Syncope.

Authors:  Patrick Badertscher; Thomas Nestelberger; Jeanne du Fay de Lavallaz; Martin Than; Beata Morawiec; Damian Kawecki; Òscar Miró; Beatriz López; F Javier Martin-Sanchez; José Bustamante; Nicolas Geigy; Michael Christ; Salvatore Di Somma; W Frank Peacock; Louise Cullen; François Sarasin; Dayana Flores; Michael Tschuck; Jasper Boeddinghaus; Raphael Twerenbold; Karin Wildi; Zaid Sabti; Christian Puelacher; Maria Rubini Giménez; Nikola Kozhuharov; Samyut Shrestha; Ivo Strebel; Katharina Rentsch; Dagmar I Keller; Imke Poepping; Andreas Buser; Wanda Kloos; Jens Lohrmann; Michael Kuehne; Stefan Osswald; Tobias Reichlin; Christian Mueller
Journal:  J Am Heart Assoc       Date:  2017-12-14       Impact factor: 5.501

7.  Brain Natriuretic Peptides in Screening of Syncope with Cardiac Origin; a Commentary.

Authors:  Hamideh Feiz Disfani; Mostafa Kamandi; Kazem Rahmani
Journal:  Emerg (Tehran)       Date:  2018-02-18

8.  Diagnosis and prevention of the vasodepressor type of neurally mediated syncope in Japanese patients.

Authors:  Misaki Hasegawa; Tomoyoshi Komiyama; Kengo Ayabe; Susumu Sakama; Tetsuri Sakai; Kyong Hee Lee; Masahiro Morise; Atsuhiko Yagishita; Mari Amino; Ayumi Sasaki; Eiichiro Nagata; Hiroyuki Kobayashi; Koichiro Yoshioka; Yuji Ikari
Journal:  PLoS One       Date:  2021-06-25       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.